A bitter lesson, but tissue engineering learns to refocus on commercial realities
This article was originally published in Clinica
During the last 18 months there has been a dramatic turn around in the commercial world of tissue engineering. The lessons being learnt are providing a new generation of tissue engineers with a solid foundation upon which to build a successful industry, says Chris Mason FRCS, of the Advanced Centre for Biochemical Engineering, UCL, London. The following is an excerpt of a paper prepared by Dr Mason for the MDT 2004 meeting in Birmingham, UK.